Immunological and immunogenetic markers in sporadic Alzheimer's disease

Calogero Caruso; Giuseppina Colonna Romano; Giuseppina Candore; Letizia Scola; Domenico Lio

Immunological and immunogenetic markers in sporadic Alzheimer's disease

Calogero Caruso, Giuseppina Colonna Romano, Giuseppina Candore, Letizia Scola, Domenico Lio

Biomedicina, Neuroscienze e Diagnostica avanzata

Risultato della ricerca: Article

11 Citazioni (Scopus)

Abstract

Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.

Lingua originale	English
pagine (da-a)	163-166
Numero di pagine	4
Rivista	Aging clinical and experimental research
Volume	18
Stato di pubblicazione	Published - 2006

Fingerprint

All Science Journal Classification (ASJC) codes

Ageing
Geriatrics and Gerontology

Cita questo

Caruso, C., Colonna Romano, G., Candore, G., Scola, L., & Lio, D. (2006). Immunological and immunogenetic markers in sporadic Alzheimer's disease. Aging clinical and experimental research, 18, 163-166.

@article{4421ec0161f649ad95c0fe582e3435f1,

title = "Immunological and immunogenetic markers in sporadic Alzheimer's disease",

abstract = "Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.",

keywords = "Alzheimer{\textquoteright}s disease, cytokines, immunogenetics, inflammation, proteomics, Alzheimer{\textquoteright}s disease, cytokines, immunogenetics, inflammation, proteomics",

author = "Calogero Caruso and {Colonna Romano}, Giuseppina and Giuseppina Candore and Letizia Scola and Domenico Lio",

year = "2006",

language = "English",

volume = "18",

pages = "163--166",

journal = "Aging clinical and experimental research",

issn = "1594-0667",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Immunological and immunogenetic markers in sporadic Alzheimer's disease

AU - Caruso, Calogero

AU - Colonna Romano, Giuseppina

AU - Candore, Giuseppina

AU - Scola, Letizia

AU - Lio, Domenico

PY - 2006

Y1 - 2006

N2 - Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.

AB - Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.

KW - Alzheimer’s disease

KW - cytokines

KW - immunogenetics

KW - inflammation

KW - proteomics

KW - Alzheimer’s disease

KW - cytokines

KW - immunogenetics

KW - inflammation

KW - proteomics

UR - http://hdl.handle.net/10447/17627

M3 - Article

VL - 18

SP - 163

EP - 166

JO - Aging clinical and experimental research

JF - Aging clinical and experimental research

SN - 1594-0667

ER -

Accesso al documento

OA Link